![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, April 20, 2015 11:39:15 AM
This PR sure surprised me. You probably have been a big buyer of these NNVC bargain shares.
Did I just read, 'who would buy a product that reduces herpes (chickenpox, genital herpes, cold sores,shingles etc etc) flair ups by 90 percent and prevents scabs and scarring? Well since Zovirax has sales of 29.2 million a quarter with a 70 percent profit margin and is only 2 percent as effective as the NNVC Herpecide findings, i'm thinking Everyone!
The whole point of a topical treatment for people who have the virus (which is 50 percent of the human population in which 30 percent are affected by the breakouts) is to apply an ointment on the initial 'itchy feeling' you get when the flair ups occur. The breakouts are the problem! There is ample warning of the breakouts and applying the topical ointment would prevent the spread and stop the breakout.
This announcement will certainly catch the attention of current Pharmaceutical ointment manufacturers. All NNVC will need to do is license the drug which will generate 100's of millions in revenue. This will certainly be the first, easiest and fastest way to generate revenue.
How anyone could spin this into a negative is (fill in the blank)
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM